Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis

International Journal of Clinical Practice

Volumn 59, Issue 7, 2005, Pages 785-790

  Chuang, F R ^a   Chang, H W ^b   Lin, C L ^a   Wang, I K ^a   Chang, H Y ^a   Wang, P H ^b   Yang, C C ^a   Chen, T C ^a   Wu, C S ^a   Lee, Chih Hsiung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Anticardiolipin antibody; Haemodialysis; Hepatitis C; Vascular access thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEPATITIS C; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATHOGENESIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TAIWAN; THROMBOSIS; VASCULAR ACCESS; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; HEPATITIS; IMMUNOLOGY; INDWELLING CATHETER; MIDDLE AGED; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY;

ANTIBODIES, ANTICARDIOLIPIN; CATHETERS, INDWELLING; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS; HUMANS; IMMUNOGLOBULIN G; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECURRENCE; REGRESSION ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 25444464877     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00493.x     Document Type: Article

References (26)

1. Harris EN, Chan JKH, Asherson RA et al. Thrombosis, recurrent fetal loss, and thrombocytopenia: Predictive value of anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-6.
2. Gronhagen-Riska C, Teppo AM, Helentera A et al. Raised concentration of antibodies to cardiolipin in patients receiving dialysis. BMJ 1990; 300: 1696-7.
3. Garcia-Martin F, De Arriba G, Carrascosa T et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991; 6: 543-7.
4. Page B, Yazbeck F, Zingraff J et al. Clotting of vascular access in dialysis patients associated to anticardiolipin antibodies. Nephrol Dial Transplant 1992; 7: 733 (Abstract).
5. Bala Subramanian V, Smith D, Mcmillan M et al. Anticardiolipin antibodies in long-term dialysis patients. Nephrol Dial Transplant 1992; 7: 459 (Abstract).
6. Chew SL, Lins RL, Daelemans R et al. Are anticardiolipin antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 1992; 14: 1194-8.
7. Sitter T, Schiffl H. Anticardiolipin antibodies in patients on regular hemodialysis: An epiphenomenon? Nephron 1993; 64: 655-6 (letter).
8. Valeri A, Joseph R, Radhakrishnan J. A large prospective survey of anti-cardiolipin antibodies in chronic hemodialysis patients. Clin Nephrol 1999; 51: 116-21.
9. Prieto LN, Suki WN. Frequent hemodialysis graft thrombosis: Association with antiphospholipid antibodies. Am J Kidney Dis 1994; 23: 587-90.
10. Prakash R, Miller CC, Suki WN. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 1995; 26: 347-52.
11. Manns BJ, Burgess ED, Parsons HG et al. Hyperhomocystenemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 1999; 55: 315-20.
12. Haviv YS. Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: Cause or effect? Nephron 2000; 86: 447-54.
13. Brunet P, Aillaud MF, San Marco M et al. Antiphospholipids on hemodialysis patients: Relationship between lupus anticoagulant and thrombosis. Kidney Int 1995; 48: 794-800.
14. Fabrizi F, Sangiorgio R, Pontoriero G et al. Antiphospholipid (aPL) antibodies in end-stage renal disease. J Nephrol 1999; 12: 89-94.
15. Cockwell P, Tse WY, Savage CO. Activation of endothelial cells in thrombosis and vasculitis. Scand J Rheumatol 1997; 26: 145-50.
16. Cervera R, Font J, Lopez-Soto A et al. Systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990; 49: 109-13.
17. Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 1992; 65: 79-82.
18. Love PE, Santoro SA. Antiphospholipid antibiodies: Anticardiolipid and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 1990; 112: 682-98.
19. Sebastiani GD, Galeazzi M, Tincani A et al. Anticardiolipin and antibeta2 GP1 antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. Scand J Rheumatol 1999; 28: 344-51.
20. Cheung AK, Dalpias D, Emmerson R et al. A prospective study on intradialytic symptoms associated with reuse of hemodialyzers. Am J Nephrol 1991; 11: 397-401.
21. Matsuda J, Saitoh N, Gotoh M et al. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha. Am J Gastroenterol 1995; 90: 1138-41.
22. Prieto J, Yuste JR, Beloqui O et al. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199-204.
23. Jacq F, Emmerich J, Heron E et al. Distal gangrene and cryoglobulinemia related to hepatitis C virus infection with presence of anticardiolipin antibodies. Rev Med Interne 1997; 18: 324-7.
24. Malnick SD, Abend Y, Evron E et al. HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Response to interferon therapy. J Clin Gastroenterol 1997; 24: 40-2.
25. Dalekos GN, Kistis KG, Boumba DS et al. Increased of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 2000; 12: 67-74.
26. Zachou K, Liaskos C, Christodoulou DK et al. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 2003; 33: 161-8.